Search results for "Mace"

showing 10 items of 4713 documents

Clay-biosurfactant materials as functional drug delivery systems: Slowing down effect in the in vitro release of cinnamic acid

2017

Abstract The main objectives of the present paper were the preparation and characterization of new surfactant-modified clays and the evaluation of their potential applicability as drug delivery systems for the oral administration of the cinnamic acid (CA) drug. The organoclays (OC) were prepared by loading different amounts of the biocompatible nonionic polyoxyethylene sorbitan monolaurate surfactant (Tween20) onto K10 montmorillonite (Mt) clay and characterized through the construction of the adsorption isotherms by means of the spectrophotometric method. The performance of the prepared material was verified by gathering the adsorption isotherms of the cinnamic acid onto the Mt/Tween20 org…

ChromatographyIntercalation (chemistry)020101 civil engineeringGeology02 engineering and technologyPharmaceutical formulation021001 nanoscience & nanotechnologyCinnamic acid0201 civil engineeringchemistry.chemical_compoundMontmorilloniteAdsorptionadsorptionHill isothermCinnammic acidMontmorillonitePolyoxyethylene sorbitan monolaurateTween 20Drug delivery systemsPulmonary surfactantchemistryGeochemistry and PetrologyDrug deliveryOrganoclay0210 nano-technologyNuclear chemistry
researchProduct

Fractal Dimension of Transdermal-Delivery Drug Models: 4-Alkylanilines

2008

Abstract The pathways that exist in porous membranes used to deliver drugs form fractal percolating paths. For a homologous series of 4-alkylanilines, the fractal dimension D is calculated as a model for transdermal-delivery drugs. Program TOPO is used for the calculation of the solvent-accessible surface AS, which is denoted by the centre of a probe, which is allowed to roll on the outside while maintaining contact with the bare molecular surface S. AS depends on the probe radius R. For 4-alkylanilines, the quadrupole moment Θ is doubled. The hydrophobic contribution to AS is doubled while its hydrophilic part remains constant. D increases 11%. Geometric descriptor and topological index re…

ChromatographyMolar concentrationChemistryStereochemistryClinical BiochemistryPharmaceutical ScienceThermodynamicsRadiusBiochemistryFractal dimensionAnalytical ChemistryPartition coefficientHomologous serieschemistry.chemical_compoundFractalTopological indexAbsorption (chemistry)Journal of Liquid Chromatography & Related Technologies
researchProduct

Multicomponent solid dispersion as a formulation strategy to improve drug permeation: A case study on the anti-colorectal cancer irinotecan

2019

Abstract Multicomponent solid dispersions (MSD)s are frequently proposed as efficient drug delivery systems to improve drug solubility and bioavailability. In this study, the effects of specific excipients, such as mannitol, inulin, poly(methyl methacrylate-co-methacrylic)acid (PMMA) and cellulose acetate phthalate (CAP) have been tested to potentially improve irinotecan (IRN) permeation in the intestinal tract with the intention to protect the drug from the gastric environment. MSDs were formulated as microparticles by Spray-Drying technique. Raw materials and microparticles have been characterized by FTIR analysis to determine hydrogen bonding. SEM images were recorded to investigate morp…

ChromatographyPharmaceutical Science02 engineering and technologyPermeation021001 nanoscience & nanotechnology030226 pharmacology & pharmacyBioavailabilityMulticomponent solid dispersion Microparticles Irinotecan Inulin Spray-drying03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCellulose acetate phthalatechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryDissolution testingParticle sizeSolubility0210 nano-technologyDissolutionJournal of Drug Delivery Science and Technology
researchProduct

Inhibition of the system luminol-H2O2-Fe(CN)63− chemiluminescence by the Mn(II) indirect determination of isoniazid in a pharmaceutical formulation

1998

A flow injection procedure for the indirect chemiluminescent determination of isoniazid is proposed. The method is performed in a flow-injection manifold provided with a solid-phase reactor. The reactor was made from manganese dioxide physically entrapped by polymerization; the redox reaction isoniazid-manganese dioxide released Mn(II) which was monitored through its inhibitory effect on the reaction between luminol and hydrogen peroxide in presence of potassium hexacyanoferrate (III). The procedure resulted in a linear calibration graph over the range 5-15 mg/L of isoniazid with a sample throughput of 43 samples/h. The influence of foreign compounds was studied and the method was applied t…

ChromatographyPotassiumBiophysicschemistry.chemical_elementManganesePharmaceutical formulationRedoxlaw.inventionLuminolchemistry.chemical_compoundchemistryPolymerizationChemistry (miscellaneous)lawHydrogen peroxideChemiluminescenceNuclear chemistryJournal of Bioluminescence and Chemiluminescence
researchProduct

On the Measurement of Dead Time in Micellar Liquid Chromatography

1996

Abstract Modelling of the retention of solutes in micellar liquid chromatography allows the optimization of the resolution of a mixture of solutes and the determination of physico-chemical retention parameters. Both tasks imply the calculation of capacity factors, which are severely affected by the value of dead time. However, the determination of the dead time is not easy when a micellar mobile phase is used owing to the wide and variable perturbations that appear at the heads of the chromatograms. Four different criteria of determination of a reference time in the chromatograms are proposed and compared. The criteria are applied to mobile phases containing a varying concentration of surfa…

ChromatographyResolution (mass spectrometry)ChemistryClinical BiochemistryAnalytical chemistryPharmaceutical ScienceDead timeBiochemistryCapacity factorAnalytical ChemistryPulmonary surfactantMicellar liquid chromatographyPhase compositionPhase (matter)Retention timeJournal of Liquid Chromatography & Related Technologies
researchProduct

Separation of U(VI) and Th(IV) from Some Rare Earths by Thin Layer Chromatography with Di‐(2‐Ethylhexyl)‐Dithiophosphoric Acid on Silica Gel

2005

Abstract Separation of U(VI) and Th(IV) from some rare earths by TLC has been studied using silica gel H and silica gel H impregnated with ammonium nitrate as the stationary phase. The solvent mixture ethyl‐methyl‐ketone–tetrahydrofuran (6∶3, v/v) containing di-(2‐ethylhexyl)-dithiophosphoric acid was used as the mobile phase. When silica gel H impregnated with 2.5 M NH4NO3 was used as stationary phase, the resolution was much improved and the separation of rare earths from each other was also achieved. The tetrad‐effect was observed in variation of R*m versus the atomic number of rare earths.

ChromatographyResolution (mass spectrometry)Silica gelAmmonium nitrateClinical BiochemistryPharmaceutical ScienceBiochemistryThin-layer chromatographyAnalytical ChemistrySolventchemistry.chemical_compoundchemistryPhase (matter)ChelationAtomic numberNuclear chemistryJournal of Liquid Chromatography & Related Technologies
researchProduct

Spectrophotometric Determination of Hydralazine with 2-Hydroxy-1-naphthaldehyde in Pharmaceuticals

1991

Abstract A new extraction-spectrophotometric method for the determination of hydralazine, based on its reaction with 2-hydroxy-1-naphthaldehyde at 25 °C, is described. The calibration curve was linear between 0.4 and 6 mg/mL of hydralazine. The molar absorbtivity of the product at 408 nm is 40 900 L · mol − 1 · cm − 1 . The method described was applied to the analysis of hydralazine in pharmaceutical preparations containing reserpine, hydrochlorothiazide, bendrofluorthiazine, propranolol, and other substances. The agreement with the U.S.P. XXI method was satisfactory for tablets and injections, but not for pellets.

ChromatographySpectrophotometry Infraredmedicine.diagnostic_testChemistryCalibration curveTemperaturePharmaceutical SciencePropranololHydrogen-Ion ConcentrationNaphthalenesReserpineHydralazineHydralazineDosage formHydrochlorothiazideSpectrophotometrySolventsmedicineIndicators and ReagentsSpectrophotometry Ultravioletmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Simultaneous dissolution profiles of two drugs in pharmaceutical formulations by an FIA manifold

2002

Abstract This article deals with the simultaneous determination of dissolution profiles of two drugs with overlapped spectra, present in the same pharmaceutical formulation. The official procedure for the dissolution profile is adapted to the continuous-flow methodology; the dissolution vessel is connected to an FIA manifold, in which the sample aliquots from the dissolution vessel are treated in order to adjust to the suitable pH and dilution degree to be monitored. The resulting solution is injected into the carrier stream, an acetic acid–acetate buffer at pH 4.3 and forced to the flow-cell of the spectrophotometer. The simultaneous determination of both profiles is based on the first der…

ChromatographySulfamethoxazoleChemistryClinical BiochemistryPharmaceutical SciencePharmaceutical formulationTrimethoprimDosage formAnalytical Chemistrylaw.inventionDilutionAnti-Infective AgentsSolubilitylawFlow Injection AnalysisDrug DiscoveryManifold (fluid mechanics)Quantitative analysis (chemistry)DissolutionSpectroscopyAnalysis methodJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Quantitative Bestimmung von Gelatine in Arzneizubereitungen durch HPLC mit fluorimetrischer Detektion

1986

Gelatine ist als pharmazeutischer Hilfsstoff fur Kapseln, Gele, Globuli und Tabletten sowie als Lebensmittelzusatzstoff unverandert wichtig. Aus Proteinen hoher Molekularmasse1 bestehend, ist Gelatine spezifischen quantitativen Bestimmungen relativ schwer zuganglich2-6.

Chromatographyfood.ingredientfoodChemistryDrug DiscoveryFluorescence spectrometryPharmaceutical ScienceMass spectrometryGelatinHigh-performance liquid chromatographyArchiv der Pharmazie
researchProduct

Candesartan Cilexetil In Vitro-In Vivo Correlation: Predictive Dissolution as a Development Tool

2020

[EN] The main objective of this investigation was to develop an in vitro-in vivo correlation (IVIVC) for immediate release candesartan cilexetil formulations by designing an in vitro dissolution test to be used as development tool. The IVIVC could be used to reduce failures in future bioequivalence studies. Data from two bioequivalence studies were scaled and combined to obtain the dataset for the IVIVC. Two-step and one-step approaches were used to develop the IVIVC. Experimental solubility and permeability data confirmed candesartan cilexetil. Biopharmaceutic Classification System (BCS) class II candesartan average plasma profiles were deconvoluted by the Loo-Riegelman method to obtain th…

Chromatographygenetic structuresChemistryPharmaceutical Sciencelcsh:RS1-441Time scalingBioequivalenceBCSArticleCandesartan cilexetillcsh:Pharmacy and materia medicaCandesartanIVIVCIn vivomedicinePredictive in vivo-dissolutionIn vitro in vivoSolubilityIVIVCDissolutionmedicine.drugBioequivalence
researchProduct